{"id":91741,"date":"2016-12-12T20:07:32","date_gmt":"2016-12-12T20:07:32","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=91741"},"modified":"2016-12-12T20:07:32","modified_gmt":"2016-12-12T20:07:32","slug":"cancer-biomarkers-market-size-analysis-trends-report-share-investment-opportunities-and-forecast-to-2022","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/cancer-biomarkers-market-size-analysis-trends-report-share-investment-opportunities-and-forecast-to-2022_91741.html","title":{"rendered":"Cancer Biomarkers Market size, Analysis, Trends, Report, Share, Investment Opportunities and Forecast to 2022"},"content":{"rendered":"<div style=\" width:250px; padding:8px 10px 10px 10px; float:right;\"><a href=\"http:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2016\/12\/1456990356.png\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"image\" src=\"http:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2016\/12\/1456990356.png\" alt=\"\" width=\"225\" height=\"73\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\" style=\" font-weight:bold; font-style:italic;\">\n<div>&#8220;Stratistics MRC, one stop shop for all your market research needs.&#8221;<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">According to Stratistics MRC, the Global Cancer Biomarkers market is estimated at $9215.32 million in 2015 and is expected to reach $20958.63 million by 2022 growing at a CAGR of 12.5% from 2015 to 2022. Technological improvements, huge investment flow for Research and Development and increasing usage in drug development and drug delivery are the factors driving the market growth.<\/div>\n<p style=\"text-align: justify;\"><span>On the other hand, Sample collection and storage issue and poor reimbursement policies are hampering the market. Growing awareness for personalized medication is the opportunity for the market growth.<\/span><\/p>\n<p style=\"text-align: justify;\"><span><strong>Order a copy at<br \/><a rel=\"nofollow\" href=\"http:\/\/www.strategymrc.com\/report\/cancer-biomarkers-market\" target=\"_blank\">http:\/\/www.strategymrc.com\/report\/cancer-biomarkers-market<\/a><br \/><\/strong><\/span><\/p>\n<p style=\"text-align: justify;\"><span>North America captured huge share in terms of revenue owing to raising awareness towards cancer diagnostics. However, Asia Pacific is anticipated to be the fastest growing region with highest CAGR during forecast period, because of increasing demand for non invasive diagnosis in this region. The diagnostics segment holds largest share in the market, followed by drug discovery and development.<\/span><\/p>\n<p style=\"text-align: justify;\"><span>Some of the key players in the market include Abbott Laboratories, Becton Dickinson and Company, Correlogic Systems, Inc., Agilent Technologies, Biomerieux S.A., Astellas Pharma US Inc., Roche Diagnostics Corp., Astex Pharmaceuticals, Agendia Bv, Diadexus, Inc., Ambrilia Biopharma, CuraGen, Gen-Probe Inc, Beckman Coulter, Inc., Clarient, Inc, Biocurex Inc., and Aureon Laboratories, Inc.<\/span><\/p>\n<p style=\"text-align: justify;\"><strong>Request for a sample at<br \/><strong><a rel=\"nofollow\" href=\"http:\/\/www.strategymrc.com\/report\/cancer-biomarkers-market\" target=\"_blank\">http:\/\/www.strategymrc.com\/report\/cancer-biomarkers-market<\/a><\/strong><br \/><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Scope of the Report:<\/strong><\/p>\n<p style=\"text-align: justify;\"><span><strong>Services Covered:<\/strong><br \/>&bull; Biomakers validation and testing<br \/>&bull; Sample preparation<br \/>&bull; Assay development<\/p>\n<p><strong>Diseases Covered:<\/strong><br \/>&bull; Lung Cancer<br \/>&bull; Cervical Cancer<br \/>&bull; Prostate Cancer<br \/>&bull; Colorectal Cancer<br \/>&bull; Breast&nbsp; Cancer<br \/>&bull; Other Cancers<\/p>\n<p><strong>Profiling Technologies Covered:<\/strong><br \/>&bull; Omics Technologies<br \/>o Transcriptomics<br \/>o Proteomics<br \/>&sect; Protein Microarray Technology<br \/>&sect; Peptide Array Technology<br \/>&sect; 2-D Gel Electrophoresis<br \/>&sect; Mass Spectrometry<br \/>&bull; Imaging Mass Spectrometry<br \/>&bull; Maldi Mass Spectrometry<br \/>&sect; Antibody Array Technology<br \/>o Genomics<br \/>&sect; Microarrays<br \/>&sect; Next Generation Sequencing (NGS)<br \/>&sect; PCR (Polymer Chain Reaction)<br \/>o Pharmacogenomics<br \/>o Metabolomics<br \/>&bull; Bioinformatics<br \/>&bull; IVD multivariate index assays<br \/>&bull; Cytogenetics<br \/>o DNA microarrays<br \/>o Ish (In Situ Hybridization)<br \/>&bull; Immunoassays<br \/>o Flow Cytometry<br \/>o Elisa<br \/>o Immunohistochemistry (IHC)<br \/>&bull; Imaging Technologies<br \/>o Mammography<br \/>o Ultrasound<br \/>o Magnetic Resonance Imaging (MRI)<br \/>o Computed Tomography (CT)<br \/>o Positron Emission Tomography (PET)<\/p>\n<p><strong>Applications Covered:<\/strong><br \/>&bull; Risk Assessment<br \/>&bull; Drug Discovery and Development<br \/>&bull; Drug formulation<br \/>&bull; Diagnostics<br \/>&bull; Prognostics<br \/>&bull; Other Applications<\/p>\n<p><strong>Types covered:<\/strong><br \/>&bull; Genetic Biomarkers<br \/>&bull; Protein Biomarkers<br \/>&bull; Other Types<br \/>o Carbohydrate biomarkers<br \/>o Cell biomarkers<br \/>o Viral biomarkers<\/p>\n<p><strong>Regions Covered:<\/strong><br \/>&bull; North America<br \/>o US<br \/>o Canada<br \/>o Mexico<br \/>&bull; Europe<br \/>o Germany<br \/>o France<br \/>o Italy<br \/>o UK&nbsp;<br \/>o Spain&nbsp;&nbsp;<br \/>o Rest of Europe&nbsp;&nbsp;&nbsp;&nbsp;<br \/>&bull; Asia Pacific<br \/>o Japan&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br \/>o China&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br \/>o India&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br \/>o Australia&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br \/>o New Zealand&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br \/>o Rest of Asia Pacific&nbsp;&nbsp;&nbsp;&nbsp;<br \/>&bull; Rest of the World<br \/>o Middle East<br \/>o Brazil<br \/>o Argentina<br \/>o South Africa<br \/>o Egypt<\/p>\n<p><strong>What our report offers:<\/strong><br \/>&#8211; Market share assessments for the regional and country level segments<br \/>&#8211; Market share analysis of the top industry players<br \/>&#8211; Strategic recommendations for the new entrants<br \/>&#8211; Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets<br \/>&#8211; Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)<br \/>&#8211; Strategic recommendations in key business segments based on the market estimations<br \/>&#8211; Competitive landscaping mapping the key common trends<br \/>&#8211; Company profiling with detailed strategies, financials, and recent developments<br \/>&#8211; Supply chain trends mapping the latest technological advancements<\/span><\/p>\n<p style=\"text-align: justify;\"><strong>Follow us on LinkedIn:&nbsp;<\/strong><strong><br \/><\/strong><a rel=\"nofollow\" href=\"https:\/\/www.linkedin.com\/company\/stratistics-market-research-consulting-pvt-ltd?trk=mini-profile\" >https:\/\/www.linkedin.com\/company\/stratistics-market-research-consulting-pvt-ltd?trk=mini-profile<\/a><\/p>\n<p style=\"text-align: justify;\"><strong>Follow us on Twitter:<\/strong><strong><br \/><\/strong><a rel=\"nofollow\" href=\"https:\/\/twitter.com\/StratisticsMRC\"  target=\"_blank\">https:\/\/twitter.com\/StratisticsMRC<\/a><\/p>\n<p style=\"text-align: justify;\"><strong>About Stratistics MRC<\/strong><\/p>\n<p style=\"text-align: justify;\">We offer wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services and Full Time Equivalent (FTE) services in the research world. We explore the market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends.<\/p>\n<p style=\"text-align: justify;\">Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects.<\/p>\n<p style=\"text-align: justify;\"><strong>For more information, please visit<\/strong>&nbsp;<a rel=\"nofollow\" href=\"http:\/\/www.strategymrc.com\/\"  target=\"_blank\">Stratistics Market Research Consulting&nbsp;Pvt Ltd<\/a><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> Stratistics Market Research Consulting<br \/><strong>Contact Person:<\/strong> James Lamb<br \/><strong>Email:<\/strong> info@strategymrc.com<br \/><strong>Phone:<\/strong> +1-301-202-5929<br \/><strong>City:<\/strong> Gaithersburg<br \/><strong>State:<\/strong> Maryland<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.strategymrc.com\" target=\"_blank\" rel=\"nofollow\">www.strategymrc.com<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/www.strategymrc.com\" style=\"width:605px; height:400px;\"><\/object><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=cancer-biomarkers-market-size-analysis-trends-report-share-investment-opportunities-and-forecast-to-2022\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;Stratistics MRC, one stop shop for all your market research needs.&#8221; According to Stratistics MRC, the Global Cancer Biomarkers market is estimated at $9215.32 million in 2015 and is expected to reach $20958.63 million by 2022 growing at a CAGR &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/cancer-biomarkers-market-size-analysis-trends-report-share-investment-opportunities-and-forecast-to-2022_91741.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-91741","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/91741","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=91741"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/91741\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=91741"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=91741"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=91741"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}